Switching to tenofovir disoproxil fumarate in entecavir-treated chronic hepatitis B patients: A pilot randomized controlled study

Although hepatitis B surface antigen (HBsAg) removal is considered the goal of chronic hepatitis B treatment, it can rarely be achieved with nucleos(t)ide analogues (NAs). It has been reported that tenofovir disoproxil fumarate (TDF) is superior in reducing HBsAg compared with entecavir (ETV) in tre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Rep
Egile Nagusiak: Inoue, Jun, Akahane, Takehiro, Kobayashi, Tomoo, Obara, Noriyuki, Umetsu, Teruyuki, Kakazu, Eiji, Ninomiya, Masashi, Iwata, Tomoaki, Sano, Akitoshi, Tsuruoka, Mio, Sato, Kosuke, Masamune, Atsushi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2021
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7739848/
https://ncbi.nlm.nih.gov/pubmed/33335726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2020.1396
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak